We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$590M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336

Top Buys

Rank Stock Value
1
BSCF
CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF
BSCF
+$96.3M
2
GWR
Genesee & Wyoming Inc.
GWR
+$59.1M
3
OII icon
Oceaneering
OII
+$56.8M
4
PNW icon
Pinnacle West Capital
PNW
+$51.3M
5
KMI icon
Kinder Morgan
KMI
+$47.3M

Top Sells

Rank Stock Value
1
BSJF
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
+$98.4M
2
BSJG
Guggenheim BulletShares 2016 High Yield Corporate Bond ETF
BSJG
+$92.9M
3
BSJH
Guggenheim BulletShares 2017 High Yield Corporate Bond ETF
BSJH
+$80M
4
BSCE
CLAYMORE GUGGENHEIM BULLETSHARES 2014 CORP BD ETF
BSCE
+$73.1M
5
WLL
Whiting Petroleum Corporation
WLL
+$59.5M

Sector Composition

Rank Sector Weight
1 Financials 10.28%
2 Technology 9.93%
3 Consumer Discretionary 9.85%
4 Healthcare 9.66%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QMCO icon
2951
Quantum Corp
QMCO
$460M
$25K ﹤0.01%
133
-8
-6% -$1.59K
RVLT
2952
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$25K ﹤0.01%
1,530
-1,736
-53% -$36.6K
LXRX icon
2953
Lexicon Pharmaceuticals
LXRX
$1.05B
$24K ﹤0.01%
2,468
-252
-9% -$2.69K
GERN icon
2954
Geron
GERN
$1.01B
$21K ﹤0.01%
10,746
-1,635
-13% -$4.03K
GEG icon
2955
Great Elm Group
GEG
$69.9M
$20K ﹤0.01%
878
-61
-6% -$1.49K
NAVB
2956
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$20K ﹤0.01%
776
-47
-6% -$1.24K
DRRX
2957
DELISTED
DURECT Corp
DRRX
$19K ﹤0.01%
1,325
-3,086
-70% -$47.8K
EDMC
2958
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
$19K ﹤0.01%
17,571
-265
-1% -$366
DNDN
2959
DELISTED
DENDREON CORPORATION
DNDN
$18K ﹤0.01%
12,756
-1,381
-10% -$2.42K
CATX icon
2960
Perspective Therapeutics
CATX
$339M
$17K ﹤0.01%
1,010
-2,352
-70% -$58.2K
LFVN icon
2961
LifeVantage
LFVN
$83M
$16K ﹤0.01%
2,014
-4,692
-70% -$43K
IRD
2962
Opus Genetics
IRD
$307M
$16K ﹤0.01%
41
-97
-70% -$34.9K
UEC icon
2963
Uranium Energy
UEC
$5.32B
$13K ﹤0.01%
10,111
-23,562
-70% -$35.5K
MDW
2964
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$13K ﹤0.01%
12,387
-28,856
-70% -$27K
KWK
2965
DELISTED
QUICKSILVER RESOURCES INC
KWK
$12K ﹤0.01%
20,480
-776
-4% -$1.18K
CNSY
2966
Cerenome, Inc. Common Stock
CNSY
$26.6M
– –
0
– –
APP
2967
DELISTED
AMERICAN APPAREL INC COM
APP
$11K ﹤0.01%
13,023
-11,199
-46% -$10.6K
URZ
2968
DELISTED
URANERZ ENERGY CORP
URZ
$11K ﹤0.01%
10,101
-23,527
-70% -$28.4K
OMEX icon
2969
Odyssey Marine Exploration
OMEX
$44M
$10K ﹤0.01%
873
-2,035
-70% -$29.7K
DFBG
2970
DELISTED
Differential Brands Group Inc
DFBG
$10K ﹤0.01%
349
-812
-70% -$26K
HTM
2971
DELISTED
U.S. Geothermal Inc.
HTM
$9K ﹤0.01%
2,540
-5,918
-70% -$22.1K
AIM
2972
AIM ImmunoTech
AIM
$7.51M
– –
-2
Closed -$30.8K
SVRA icon
2973
Savara
SVRA
$1.19B
$7K ﹤0.01%
191
-446
-70% -$18.8K
RCPI
2974
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$6K ﹤0.01%
+833
New +$8.23K
WTSL
2975
DELISTED
WET SEAL INC CL-A
WTSL
$6K ﹤0.01%
+10,684
New +$8.92K
117 118
119
120 121

Similar funds

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.